Please assess the completion status of the following clinical trial:

Trial Title: Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age ≥18 years~2. OHCA of presumed cardiac cause~3. Unconsciousness (GCS ≤8) upon pre-hospital randomization~4. Sustained ROSC for at least 5 minutes~5. Randomization and start of study medicine infusion within 30 minutes of sustained ROSC.~Exclusion Criteria:~1. Advanced life support termination-of-resuscitation exclusion criteria~2. Asystole as primary ECG rhythm~3. Women of childbearing capacity~4. Known therapy limitation~5. Known allergy to methylprednisolone~6. Known pre-arrest modified Rankin Scale (mRS) score of 4-5~7. Temperature upon randomization \<30° C~8. \>30 minutes to sustained ROSC.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Methylprednisolone (Type: ACTIVE_COMPARATOR): A five minutes bolus infusion of 250 mg (4 mL) methylprednisolone to inhibit inflammatory and neurological damage following resuscitated out-of-hospital cardiac arrest. The infusion of methylprednisolone will be given following five minutes of sustainable ROSC in the prehospital setting.
- Isotonic saline (Type: PLACEBO_COMPARATOR): A bolus infusion of 4 mL isotonic saline (NaCl 0.9%).

Based on this trial design, predict the completion outcome and termination type (if applicable).